Fusion gene information | Fusion gene name: ALG6-GNAS |
Fusion gene ID: hg29929tg2778 | | Hgene | Tgene | Gene symbol | ALG6 | GNAS | Gene ID | 29929 | 2778 | Gene name | ALG6 alpha-1,3-glucosyltransferase | GNAS complex locus |
Synonyms | CDG1C | AHO|C20orf45|GNAS1|GPSA|GSA|GSP|NESP|PITA3|POH|SCG6|SgVI |
Cytomap | ('ALG6')('GNAS') 1p31.3 | 20q13.32 |
Type of gene | protein-coding | protein-coding |
Description | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferaseMan(9)GlcNAc(2)-PP-Dol alpha-1,3-glucosyltransferaseasparagine-linked glycosylation 6 homolog (S. cerevisiae, alpha-1,3-glucosyltransferase)asparagine-linked glycosylation 6 homolog (yeast | protein ALEXprotein GNASprotein SCG6 (secretogranin VI)G protein subunit alpha Sadenylate cyclase-stimulating G alpha proteinalternative gene product encoded by XL-exonextra large alphas proteinguanine nucleotide binding protein (G protein), alpha |
Modification date | 20200313 | 20200329 |
UniProtAcc | . | . |
Ensembl transtripts involved in fusion gene | ENST00000263440, ENST00000371108, ENST00000494765, | |
Fusion gene scores | * DoF score | 10 X 8 X 6=480 | 111 X 41 X 18=81918 |
# samples | 10 | 111 |
** MAII score | log2(10/480*10)=-2.26303440583379 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(111/81918*10)=-6.20554891117303 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 |
Context | PubMed: ALG6 [Title/Abstract] AND GNAS [Title/Abstract] AND fusion [Title/Abstract] |
Most frequent breakpoint | ALG6(63868001)-GNAS(57486111), # samples:1
|
Anticipated loss of major functional domain due to fusion event. | |
Hgene | Tgene |
. | . |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | ALG6 | C2930997 | Congenital disorder of glycosylation type 1C | 8 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Tgene | | C3494506 | Pseudohypoparathyroidism, Type Ia | 17 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Tgene | | C0242292 | McCune-Albright Syndrome | 7 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Tgene | | C0016065 | Polyostotic fibrous dysplasia | 5 | CTD_human;ORPHANET |
Tgene | | C1864100 | PSEUDOHYPOPARATHYROIDISM, TYPE IB | 5 | CTD_human;GENOMICS_ENGLAND;ORPHANET |
Tgene | | C2931404 | Albright's hereditary osteodystrophy | 4 | CTD_human;GENOMICS_ENGLAND |
Tgene | | C0033806 | Pseudohypoparathyroidism | 3 | CTD_human |
Tgene | | C0334041 | Osteoma cutis | 3 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Tgene | | C0014130 | Endocrine System Diseases | 2 | CTD_human |
Tgene | | C0016064 | Fibrous Dysplasia, Monostotic | 2 | ORPHANET |
Tgene | | C0034013 | Precocious Puberty | 2 | CTD_human |
Tgene | | C0221263 | Cafe-au-Lait Spots | 2 | CTD_human |
Tgene | | C0271527 | Cryptogenic sexual precocity | 2 | CTD_human |
Tgene | | C0342543 | Central Precocious Puberty | 2 | CTD_human |
Tgene | | C1504412 | Testotoxicosis | 2 | CTD_human |
Tgene | | C1857451 | Acth-Independent Macronodular Adrenal Hyperplasia | 2 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Tgene | | C2932716 | Pseudohypoparathyroidism Type 1C | 2 | GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Tgene | | C0001206 | Acromegaly | 1 | CTD_human |
Tgene | | C0001624 | Adrenal Gland Neoplasms | 1 | CTD_human |
Tgene | | C0003129 | Anoxemia | 1 | CTD_human |
Tgene | | C0003130 | Anoxia | 1 | CTD_human |
Tgene | | C0008370 | Cholestasis | 1 | GENOMICS_ENGLAND |
Tgene | | C0009438 | Common Bile Duct Calculi | 1 | CTD_human |
Tgene | | C0011573 | Endogenous depression | 1 | PSYGENET |
Tgene | | C0019087 | Hemorrhagic Disorders | 1 | CTD_human |
Tgene | | C0020538 | Hypertensive disease | 1 | CTD_human |
Tgene | | C0020796 | Profound Mental Retardation | 1 | CTD_human |
Tgene | | C0021655 | Insulin Resistance | 1 | CTD_human |
Tgene | | C0023897 | Liver Diseases, Parasitic | 1 | CTD_human |
Tgene | | C0025363 | Mental Retardation, Psychosocial | 1 | CTD_human |
Tgene | | C0027819 | Neuroblastoma | 1 | CTD_human |
Tgene | | C0028754 | Obesity | 1 | CTD_human |
Tgene | | C0029396 | Heterotopic Ossification | 1 | CTD_human |
Tgene | | C0032460 | Polycystic Ovary Syndrome | 1 | CTD_human |
Tgene | | C0033835 | Pseudopseudohypoparathyroidism | 1 | CTD_human;GENOMICS_ENGLAND;ORPHANET |
Tgene | | C0035204 | Respiration Disorders | 1 | CTD_human |
Tgene | | C0036341 | Schizophrenia | 1 | PSYGENET |
Tgene | | C0038587 | Substance Withdrawal Syndrome | 1 | CTD_human |
Tgene | | C0039231 | Tachycardia | 1 | CTD_human |
Tgene | | C0080203 | Tachyarrhythmia | 1 | CTD_human |
Tgene | | C0086189 | Drug Withdrawal Symptoms | 1 | CTD_human |
Tgene | | C0087169 | Withdrawal Symptoms | 1 | CTD_human |
Tgene | | C0206698 | Cholangiocarcinoma | 1 | CTD_human |
Tgene | | C0221357 | Brachydactyly | 1 | CTD_human |
Tgene | | C0242184 | Hypoxia | 1 | CTD_human |
Tgene | | C0242216 | Biliary calculi | 1 | CTD_human |
Tgene | | C0345905 | Intrahepatic Cholangiocarcinoma | 1 | CTD_human |
Tgene | | C0346302 | Growth Hormone-Secreting Pituitary Adenoma | 1 | CTD_human |
Tgene | | C0700292 | Hypoxemia | 1 | CTD_human |
Tgene | | C0750887 | Adrenal Cancer | 1 | CTD_human |
Tgene | | C0917816 | Mental deficiency | 1 | CTD_human |
Tgene | | C0920563 | Insulin Sensitivity | 1 | CTD_human |
Tgene | | C1136382 | Sclerocystic Ovaries | 1 | CTD_human |
Tgene | | C2932715 | Pseudohypoparathyroidism Type 1B | 1 | CTD_human;GENOMICS_ENGLAND;ORPHANET |
Tgene | | C3489630 | Somatotrophinoma, Familial | 1 | CTD_human |
Tgene | | C3697137 | Fibrous dysplasia of bone with intramuscular myxoma | 1 | ORPHANET |
Tgene | | C3714756 | Intellectual Disability | 1 | CTD_human |
Tgene | | C3805278 | Extrahepatic Cholangiocarcinoma | 1 | CTD_human |